Evidence map›Paper›PMID 40507943›Full record

ReviewInternational journal of molecular sciences2025

Hyaluronan: An Architect and Integrator for Cancer and Neural Diseases.

Che-Yu Hsu, Hieu-Huy Nguyen-Tran, Yu-An Chen, Kuan-Ting Lee, Tzong-Yuan Juang, Ming-Fu Chiang, Shin-Yi Liu, Nan-Shan Chang

Erratum issuedAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Che-Yu HsuDepartment of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.ORCID 0000-0002-3813-7972
Hieu-Huy Nguyen-TranGraduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0003-3589-2443
Yu-An ChenGraduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei 10617, Taiwan .
Kuan-Ting LeeGraduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0002-6360-1685
Tzong-Yuan JuangDepartment of Cosmeceutics, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0001-6373-9687
Ming-Fu ChiangDepartment of Neurosurgery, Fu Jen Catholic University Hospital, Taipei 24352, Taiwan.
Shin-Yi LiuGraduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0003-1015-6503
Nan-Shan ChangGraduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0002-6889-8756

Funding

Ministry of Science and Technology, Taiwan MOST 107-2320-B-006-005Ministry of Science and Technology, Taiwan MOST 107-2320-B-006-058-MY3National Science and Technology Council, Taiwan NSTC 113-2320-B-039-006National Science and Technology Council, Taiwan NSTC 113-2320-B-039-021
6 · The paper itself

Abstract

Hyaluronan (HA) is essentially secreted by every cell and plays a critical role in maintaining normal cell physiology. While the structure and function of HA have been extensively investigated, questions regarding the sizes and conformation of HA under physiological and inflamed conditions, in relevance to its functions, remain elusive. In this article, we update our knowledge of the HA functional properties, including binding proteins and their signaling networks, as well as matrix formation, which can potentially induce phase separation and affect the mobility and behavior of small molecules, proteins, and cells. We detail the striking differences regarding the biological outcomes of signaling pathways for HA and membrane receptors versus HA and GPI-linked hyaluronidase Hyal-2. We describe: (1) the native, large-sized HA is not proapoptotic but signals with an overexpressed HYAL-2/WWOX/SMAD4 complex to induce apoptosis, which is likely to occur in an inflamed microenvironment; (2) HA-binding proteins are connected via signal pathway networks. The competitive binding of HA and TGF-β to the membrane HYAL-2 and the downstream HYAL-2/WWOX/SMAD4 signaling is addressed; (3) the phase-separated proteins or small molecules in the HA matrices may contribute to the aberrant interactions, leading to inflammation and disease progression; (4) the role of HA and complement C1q in Alzheimer's disease via connection with a risk factor for Alzheimer's disease WWOX is also discussed; (5) a hidden function is the inducible HA conformational changes that confer cancer suppression and, probably, retardation of neurodegeneration.

Indexed as

Hyaluronic AcidNeoplasmsNervous System DiseasesAnimalsHumansHyaluronoglucosaminidaseSignal TransductionHyaluronic AcidHyaluronoglucosaminidasebinding proteinscancer progressionhyaluronanhyaluronidasesneural diseasesreceptorssignaling pathways

Identifiers

PMID40507943
PMCPMC12155404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.